Cargando…

NCAPG Promotes The Proliferation Of Hepatocellular Carcinoma Through PI3K/AKT Signaling

PURPOSE: Studies show that high expression of non-SMC condensin I complex subunit G (NCAPG) is associated with many tumors. In this study, we explore the mechanism by which NCAPG promotes proliferation in hepatocellular carcinoma (HCC). PATIENTS AND METHODS: Liver cancer and paracancerous tissue spe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gong, Chengwu, Ai, Jiyuan, Fan, Yun, Gao, Jun, Liu, Weiwei, Feng, Qian, Liao, Wenjun, Wu, Linquan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6801502/ https://www.ncbi.nlm.nih.gov/pubmed/31802891 http://dx.doi.org/10.2147/OTT.S217916

Ejemplares similares

MicroRNA‑181c suppresses growth and metastasis of hepatocellular carcinoma by modulating NCAPG
por: Ai, Jiyuan, et al.
Publicado: (2019)

NCAPG promotes the proliferation of hepatocellular carcinoma through the CKII-dependent regulation of PTEN
por: Zhang, Rongguiyi, et al.
Publicado: (2022)

NCAPG Induces Cell Proliferation in Cardia Adenocarcinoma via PI3K/AKT Signaling Pathway
por: Zhang, Xinxin, et al.
Publicado: (2020)

miR-29a suppresses the growth and metastasis of hepatocellular carcinoma through IFITM3
por: Liang, Yiming, et al.
Publicado: (2018)

Circular RNA MYLK Promotes Hepatocellular Carcinoma Progression Through the miR29a/KMT5C Signaling Pathway
por: Gao, Jun, et al.
Publicado: (2020)

IFITM3 promotes hepatocellular carcinoma invasion and metastasis by regulating MMP9 through p38/MAPK signaling
por: Min, Jiaqi, et al.
Publicado: (2018)

TUG1 promotes the expression of IFITM3 in hepatocellular carcinoma by competitively binding to miR-29a
por: Liu, Weiwei, et al.
Publicado: (2021)

NCAPG Promotes the Proliferation of Renal Clear Cell Carcinoma via Mediating with CDK1
por: Li, Huibing, et al.
Publicado: (2022)

Tollip promotes hepatocellular carcinoma progression via PI3K/AKT pathway
por: Huang, Lu, et al.
Publicado: (2022)

Erratum to “Tollip promotes hepatocellular carcinoma progression via PI3K/AKT pathway”
por: Huang, Lu, et al.
Publicado: (2022)

Chronic stress promotes glioma cell proliferation via the PI3K/Akt signaling pathway
por: Zhang, Zi-Qian, et al.
Publicado: (2021)

Overexpression of Rab40b Promotes Hepatocellular Carcinoma Cell Proliferation and Metastasis via PI3K/AKT Signaling Pathway
por: Shi, Li-Wei, et al.
Publicado: (2020)

ADORA1 Promotes Hepatocellular Carcinoma Progression via PI3K/AKT Pathway
por: Ni, Sheng, et al.
Publicado: (2020)

NCAPG as a Novel Prognostic Biomarker in Glioma
por: Jiang, Xiulin, et al.
Publicado: (2022)

NCAPG promotes the progression of lung adenocarcinoma via the TGF-β signaling pathway
por: Wu, Yun, et al.
Publicado: (2021)

PLAG1 and NCAPG‐LCORL in livestock
por: Takasuga, Akiko
Publicado: (2016)

NCAPG2 promotes tumour proliferation by regulating G2/M phase and associates with poor prognosis in lung adenocarcinoma
por: Zhan, Ping, et al.
Publicado: (2016)

NCAPG Promotes Tumor Progression and Modulates Immune Cell Infiltration in Glioma
por: Zheng, Guangrong, et al.
Publicado: (2022)

MicroRNA-3127 promotes cell proliferation and tumorigenicity in hepatocellular carcinoma by disrupting of PI3K/AKT negative regulation
por: Jiang, Jianxin, et al.
Publicado: (2015)

HnRNP-F promotes the proliferation of bladder cancer cells mediated by PI3K/AKT/FOXO1
por: Li, Fei, et al.
Publicado: (2021)

A novel peptide promotes human trophoblast proliferation and migration through PI3K/Akt/mTOR signaling pathway
por: Ling, Li, et al.
Publicado: (2021)

The Silencing of Pokemon Attenuates the Proliferation of Hepatocellular Carcinoma Cells In Vitro and In Vivo by Inhibiting the PI3K/Akt Pathway
por: Lin, Chan-Chan, et al.
Publicado: (2012)

NCAPG2 Is a Novel Prognostic Biomarker and Promotes Cancer Stem Cell Maintenance in Low-Grade Glioma
por: Ren, Wenjun, et al.
Publicado: (2022)

NCAPG2 overexpression promotes hepatocellular carcinoma proliferation and metastasis through activating the STAT3 and NF-κB/miR-188-3p pathways
por: Meng, Fanzheng, et al.
Publicado: (2019)

NCAPG2 Maintains Cancer Stemness and Promotes Erlotinib Resistance in Lung Adenocarcinoma
por: Jiang, Shiyao, et al.
Publicado: (2022)

piRNA-31115 Promotes Cell Proliferation and Invasion via PI3K/AKT Pathway in Clear Cell Renal Carcinoma
por: Du, Xinghua, et al.
Publicado: (2021)

Silencing of Peroxiredoxin 1 Inhibits the Proliferation of Esophageal Cancer Cells and Promotes Apoptosis by Inhibiting the Activity of the PI3K/AKT Pathway
por: Song, Yingjian, et al.
Publicado: (2019)

KIF11 promotes cell proliferation via ERBB2/PI3K/AKT signaling pathway in gallbladder cancer
por: Wei, Dang, et al.
Publicado: (2021)

Effect of nicastrin on hepatocellular carcinoma proliferation and apoptosis through PI3K/AKT signalling pathway modulation
por: Wang, Xicheng, et al.
Publicado: (2020)

Non-SMC Condensin I Complex, Subunit G (NCAPG) is a Novel Mitotic Gene Required for Hepatocellular Cancer Cell Proliferation and Migration
por: Zhang, Qun, et al.
Publicado: (2018)

NCAPG Is a Promising Therapeutic Target Across Different Tumor Types
por: Xiao, Cuicui, et al.
Publicado: (2020)

SETD1A promotes the proliferation and glycolysis of nasopharyngeal carcinoma cells by activating the PI3K/Akt pathway
por: Huang, Jianyi, et al.
Publicado: (2022)

VEGFB Promotes Myoblasts Proliferation and Differentiation through VEGFR1-PI3K/Akt Signaling Pathway
por: Ling, Mingfa, et al.
Publicado: (2021)

TTK activates Akt and promotes proliferation and migration of hepatocellular carcinoma cells
por: Liu, Xing, et al.
Publicado: (2015)

Genome-wide CRISPR knockout screens identify NCAPG as an essential oncogene for hepatocellular carcinoma tumor growth
por: Wang, Yu, et al.
Publicado: (2019)

PCDH10 gene inhibits cell proliferation and induces cell apoptosis by inhibiting the PI3K/Akt signaling pathway in hepatocellular carcinoma cells
por: Ye, Mingxin, et al.
Publicado: (2017)

TRMT6 promotes hepatocellular carcinoma progression through the PI3K/AKT signaling pathway
por: Ye, Yanqing, et al.
Publicado: (2023)

Rare anatomic variation of the right hepatic artery and accessory right hepatic artery supplying hepatocellular carcinoma: A case report and literature review
por: Liang, Yiming, et al.
Publicado: (2017)

TFAP4 Promotes Hepatocellular Carcinoma Invasion and Metastasis via Activating the PI3K/AKT Signaling Pathway
por: Huang, Tao, et al.
Publicado: (2019)

UBE2T promotes proliferation and regulates PI3K/Akt signaling in renal cell carcinoma
por: Hao, Peng, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_2mln41ap1dvfnu1uk96hmh13ep